Journal Article > LetterFull Text
Lancet. 2022 July 2; Volume 400 (Issue 10345); 23.; DOI:10.1016/S0140-6736(22)01187-4
Abbara A, Rao B, Titanji BK, Boum Y, Zumla A
Lancet. 2022 July 2; Volume 400 (Issue 10345); 23.; DOI:10.1016/S0140-6736(22)01187-4
Journal Article > CommentaryAbstract Only
BMJ. 2023 February 6; Volume 380; e073352.; DOI:10.1136/bmj-2022-073352
Mansour R, Houston A, Majeed A, Boum Y, Nakouné E, et al.
BMJ. 2023 February 6; Volume 380; e073352.; DOI:10.1136/bmj-2022-073352
What you need to know:
-- Consider coinfections with monkeypox and other sexually transmitted infections among patients presenting with an acute rash or skin lesions and systemic symptoms.
-- While it is safe to manage monkeypox patients virtually, they may need advice to maintain infection control measures and interventions to manage complications.
-- A specialist infectious disease unit with access to novel antivirals such as tecovirimat and cidofovir should manage high risk patients.
-- Healthcare workers should be aware of the stigma surrounding monkeypox, which may result in reduced health-seeking behaviours; healthcare staff should screen patients sensitively, using inclusive language to avoid alienating patients.
-- Consider coinfections with monkeypox and other sexually transmitted infections among patients presenting with an acute rash or skin lesions and systemic symptoms.
-- While it is safe to manage monkeypox patients virtually, they may need advice to maintain infection control measures and interventions to manage complications.
-- A specialist infectious disease unit with access to novel antivirals such as tecovirimat and cidofovir should manage high risk patients.
-- Healthcare workers should be aware of the stigma surrounding monkeypox, which may result in reduced health-seeking behaviours; healthcare staff should screen patients sensitively, using inclusive language to avoid alienating patients.